Kevin Y. Qian, a partner of MWE China Law Offices, advises companies on their direct investments in China. Show More
Kevin Y. Qian, a partner of MWE China Law Offices, advises companies on their direct investments in China.
Kevin has represented hundreds of multinationals and Fortune 500 companies on matters that include investments into a joint venture company or establishing a wholly owned company, cross-border mergers and acquisitions, venture capital and private equity investments, and strategic alliances. He has experience in a wide range of industries and areas, from manufacturing, energy and chemicals, to health care, pharmaceuticals, food and beverages, and commercial retail.
Kevin also heads MWE China’s Private Client Practice Group, with an extraordinary focus on clients’ specific, unique objectives, and has extensive experience in serving high-net-worth individuals and families in taxation, wealth transfer, estate and business planning, and divorce matters.
In addition to his more than 25 years of legal practice, Kevin’s experience includes roles as the following:
Faculty member of the East China University of Political Science and Law
Lawyer at a prominent Shanghai-based law firm, where he focused his practice on financial, commercial and intellectual property law
Partner of the largest law firm in Shanghai, where he served as a key director of its executive committee
Senior legal counsel of Philips Electronics in Asia, where he was responsible for legal matters concerning Philips’ 30 wholly owned and joint venture enterprises throughout the region
Deputy general manager and legal counsel for PepsiCo Investment China Co., Ltd., where he managed more than 40 wholly owned and joint venture enterprises in the beverage, restaurant and snack food industries
Head of the Asia Pacific and China Practice Group at a leading US law firm
Currently, Kevin serves as an independent director of China Minsheng Property Investment Corp., Ltd. He also served as an independent director of SAIC Motor Corporation, Ltd. and Shanghai Jiao Da Onlly Co., Ltd.
Represented a Switzerland-based global manufacturer of pharmaceutical products in the establishment of its active pharmaceutical ingredient (API) manufacturing plant in China, as well as in its acquisition of a Taiwan-listed pharmaceutical manufacturer
Assisted one of the world’s largest drug-development services companies in designing its investment strategy for the establishment of a research and development (R&D) center in China, creating a structure that enabled the company to implement its near- and long-term development plans in accordance with China’s complex land use, foreign investment, tax and administrative law regulations
Advised a multinational conglomerate on its health care and environmental compliance project in China
Represented a US-listed pharmaceutical company in its acquisition of several local, multimillion-dollar (US) life science companies in designing an acquisition vehicle structure, conducting legal due diligence, drafting documents and securing all relevant governmental approval; also represented the company in its divestiture of a photoflash business to a Singapore buyer
Represented a leading global agricultural company in its acquisition of assets of a local food company totaling US$250 million as part of its global acquisition of the dehydrated vegetable products business and operating assets of a US-based packaged foods company
Represented a Switzerland-based global manufacturer of pharmaceutical products in its acquisition of a Taiwan-listed pharmaceuticals manufacturer
Represented a US-based fund company in acquiring majority equity interests of a Zhejiang-based seeds company by conducting legal due diligence and drafting and negotiating transaction documents, for a total purchase price of US$100 million; also represented the fund company in acquiring majority equity interests of a Changzhou-based chemical company by designing the structure, conducting legal due diligence, drafting and negotiating transaction documents, and managing the closing formalities in a transaction with a total purchase price of RMB160 million
Represented a US- and UK-based private equity fund in its US$23 million portfolio investment in China’s forest and farm industry, including carrying out transaction design, documentation and legal due diligence
Represented a joint venture formed by a US fund and an Asia-based commodities firm to invest in one of China’s largest mining companies; this is the first case in which a foreign private equity (PE) fund successfully exited from a Chinese domestic company through a Chinese stock market
The affiliated firms of MWE China Law Offices and McDermott Will & Emery have lawyers educated and qualified in China, the United States and Europe. Together, the firms are able to staff Chinese cross-border projects with lawyers who are qualified and experienced in China and in the other country involved in the project.
Kevin was ranked as leading lawyer in Corporate/M&A (PRC Firms) by Chambers Global 2015 and Chambers Asia-Pacific 2015
In 2012, Kevin was awarded honor of “Leading Talents of Independent Innovation” by Huangpu District Government
The Chairman of International Law Committee of the All China Lawyers Association from 2011 to 2014
Recognized as one of Asia-Pacific’s Leading Lawyers in China by Asia Law Leading Lawyers from 2010 to 2015
The Program Coordinator of IPBA from 2009 to 2011
The Vice President of the Foreign Affairs & WTO Committee of the All China Lawyers Association since 2007
One of the World’s Leading Practitioners by the International Who’s Who of Corporate Governance Lawyers 2006
One of the Hot 30 Lawyers as well as one of the Asia Pacific’s Hot 100 in China by Asian Legal Business magazine in 2004 and 2005
The first Chinese lawyer selected as Chairman of the Inter-Pacific Bar Association (IPBA) International Trade Committee in 2004
Recognized as one of Asia’s Leading Business Lawyers by Asian Legal Business for his outstanding practice in corporate, more specially capital markets, corporate finance, and M&A from 2002 to 2008
A member of the World Trade Organisation (WTO) Committee of All China Lawyers Association in 2002
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.